Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ULTRASCALP
2024-520320-28-00Phase 4Authorised
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine + epinephrine and ropivacaine in postoperative pain (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Composite immediate postoperative pain and opioid requirement. Planned start Jun 2025; status: authorised.
02
Drugs
lidocaine + epinephrineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2024-520320-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520320-28-00.